Objective Olfactory and emotional dysfunctions are very common in patients with Parkinson’s disease (PD). Olfaction and emotions share common neuroanatomical substrates. Therefore, in this study, we evaluated the association between olfactory and emotional dysfunctions in patients with PD. Methods Parkinson’s disease patients who had been assessed for their olfactory function and neuropsychiatric symptoms including emotional dysfunction were included. A logistic regression analysis was performed to evaluate the association between low olfaction and different neuropsychiatric symptoms. Results The patients with low olfaction (cross cultural smell identification test score ≤ 6) showed a higher prevalence of apathy when compared with those with high olfaction, whereas the frequencies of other neuropsychiatric symptoms were comparable between the two groups. A multivariate logistic regression analysis revealed that the presence of apathy/indifference [odds ratio (OR) = 2.859, p = 0.007], age 70 years or more (OR = 2.281, p = 0.009), and the male gender (OR = 1.916, p = 0.030) were significantly associated with low olfaction. Conclusions Our results demonstrate that apathy/indifference is a unique emotional dysfunction associated with olfactory dysfunction in PD. The findings also suggest that PD patients with low olfaction have a high prevalence of apathy.
Citations
Citations to this article as recorded by
What does it mean when the pleasant smells come and go? Correlation between UPSIT odor identification status and fluctuation of non-motor symptoms in Parkinson’s disease Hsin-Bei Lei, Ting-Chun Fang, Yu-Hsuan Lin, Shih-Chi Chiu, Ming-Hong Chang, Yi-Jen Guo Acta Neurologica Belgica.2025;[Epub] CrossRef
Clinical features and neurobiochemical mechanisms of olfactory dysfunction in patients with Parkinson disease Ruidan Wang, Tenghong Lian, Mingyue He, Peng Guo, Shuyang Yu, Lijun Zuo, Yang Hu, Wei Zhang Journal of Neurology.2024; 271(4): 1959. CrossRef
China’s Modified Version of Sniffin’ Sticks 12‐Identification Test Used in Chinese Parkinson’s Disease and Multiple System Patients: Comparison of Three Olfactory Testing Methods Huijing Liu, Wei Du, Shuhua Li, Ying Jin, Haibo Chen, Wen Su, Cristine Alves da Costa Parkinson's Disease.2024;[Epub] CrossRef
Neurons, Nose, and Neurodegenerative Diseases: Olfactory Function and Cognitive Impairment Irene Fatuzzo, Giovanni Francesco Niccolini, Federica Zoccali, Luca Cavalcanti, Mario Giuseppe Bellizzi, Gabriele Riccardi, Marco de Vincentiis, Marco Fiore, Carla Petrella, Antonio Minni, Christian Barbato International Journal of Molecular Sciences.2023; 24(3): 2117. CrossRef
Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s disease Fardin Nabizadeh, Kasra Pirahesh, Elham Khalili Neurological Sciences.2022; 43(7): 4193. CrossRef
The Power of Odor Persuasion: The Incorporation of Olfactory Cues in Virtual Environments for Personalized Relaxation Silvia Francesca Maria Pizzoli, Dario Monzani, Ketti Mazzocco, Emanuela Maggioni, Gabriella Pravettoni Perspectives on Psychological Science.2022; 17(3): 652. CrossRef
Olfaction and apathy in early idiopathic Parkinson's disease Alfonso E. Martinez-Nunez, Kaitie Latack, Miguel Situ-Kcomt, Abhimanyu Mahajan Journal of the Neurological Sciences.2022; 439: 120314. CrossRef
Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype Ségolène De Waele, Patrick Cras, David Crosiers Brain Sciences.2022; 12(7): 923. CrossRef
α‐Synuclein Spread from Olfactory Bulb Causes Hyposmia, Anxiety, and Memory Loss in BAC‐SNCA Mice Norihito Uemura, Jun Ueda, Toru Yoshihara, Masashi Ikuno, Maiko T. Uemura, Hodaka Yamakado, Masahide Asano, John Q. Trojanowski, Ryosuke Takahashi Movement Disorders.2021; 36(9): 2036. CrossRef
Hyposmia may predict development of freezing of gait in Parkinson’s disease Jae Jung Lee, Jin Yong Hong, Jong Sam Baik Journal of Neural Transmission.2021; 128(6): 763. CrossRef
Clinical and Dopamine Depletion Patterns in Hyposmia- and Dysautonomia-Dominant Parkinson’s Disease Han Soo Yoo, Sangwon Lee, Seong Ho Jeong, Byoung Seok Ye, Young H. Sohn, Mijin Yun, Phil Hyu Lee Journal of Parkinson's Disease.2021; 11(4): 1703. CrossRef
Is There a Shared Etiology of Olfactory Impairments in Normal Aging and Neurodegenerative Disease? Mahraz Parvand, Catharine H. Rankin, Lori Beason-Held Journal of Alzheimer's Disease.2020; 73(1): 1. CrossRef
Open questions on the nature of Parkinson’s disease: from triggers to spreading pathology Lei Mou, Wei Ding, Pedro Fernandez-Funez Journal of Medical Genetics.2020; 57(2): 73. CrossRef
Effect of Olfactory and Gustatory Dysfunction and Motor Symptoms on Body Weight in Patients with Parkinson’s Disease Carla Masala, Francesco Loy, Raffaella Piras, Anna Liscia, Laura Fadda, Alan Moat, Paolo Solla, Giovanni Defazio Brain Sciences.2020; 10(4): 218. CrossRef
Insula and Amygdala Atrophy Are Associated With Functional Impairment in Subjects With Presbycusis Chama Belkhiria, Rodrigo C. Vergara, Simón San Martin, Alexis Leiva, Melissa Martinez, Bruno Marcenaro, Maricarmen Andrade, Paul H. Delano, Carolina Delgado Frontiers in Aging Neuroscience.2020;[Epub] CrossRef
Contribution of Five Functional Loci of Dopamine Metabolism-Related Genes to Parkinson’s Disease and Multiple System Atrophy in a Chinese Population Yongping Chen, Ruwei Ou, Lingyu Zhang, Xiaojing Gu, Xiaoqin Yuan, Qian-qian Wei, Bei Cao, Bi Zhao, Ying Wu, Huifang Shang Frontiers in Neuroscience.2020;[Epub] CrossRef
Olfactory Dysfunction Predicts Disease Progression in Parkinson’s Disease: A Longitudinal Study Runcheng He, Yuwen Zhao, Yan He, Yangjie Zhou, Jinxia Yang, Xiaoting Zhou, Liping Zhu, Xun Zhou, Zhenhua Liu, Qian Xu, Qiying Sun, Jieqiong Tan, Xinxiang Yan, Beisha Tang, Jifeng Guo Frontiers in Neuroscience.2020;[Epub] CrossRef
Characteristics of apathy in treatment-naïve patients with Parkinson’s disease Hiroo Terashi, Yuki Ueta, Haruhisa Kato, Hiroshi Mitoma, Hitoshi Aizawa International Journal of Neuroscience.2019; 129(1): 16. CrossRef
Olfaction and taste in Parkinson’s disease: the association with mild cognitive impairment and the single cognitive domain dysfunction Maria Paola Cecchini, Angela Federico, Alice Zanini, Elisa Mantovani, Carla Masala, Michele Tinazzi, Stefano Tamburin Journal of Neural Transmission.2019; 126(5): 585. CrossRef
The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function Dragos Mihaila, Jordan Donegan, Sarah Barns, Daria LaRocca, Qian Du, Danny Zheng, Michael Vidal, Christopher Neville, Richard Uhlig, Frank A. Middleton, Brenda A Wilson PLOS ONE.2019; 14(6): e0218252. CrossRef
Hyposmia as a marker of (non-)motor disease severity in Parkinson’s disease Dareia S. Roos, Jos W. R. Twisk, Pieter G. H. M. Raijmakers, Richard L. Doty, Henk W. Berendse Journal of Neural Transmission.2019; 126(11): 1471. CrossRef
Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson’s disease Carla Masala, Paolo Solla, A. Liscia, G. Defazio, L. Saba, A. Cannas, A. Cavazzana, T. Hummel, A. Haehner Journal of Neurology.2018; 265(8): 1764. CrossRef
Olfactory Dysfunction as an Early Biomarker in Parkinson’s Disease Michelle E. Fullard, James F. Morley, John E. Duda Neuroscience Bulletin.2017; 33(5): 515. CrossRef
Human behavioral assessments in current research of Parkinson’s disease Tetsuya Asakawa, Huan Fang, Kenji Sugiyama, Takao Nozaki, Susumu Kobayashi, Zhen Hong, Katsuaki Suzuki, Norio Mori, Yilin Yang, Fei Hua, Guanghong Ding, Guoqiang Wen, Hiroki Namba, Ying Xia Neuroscience & Biobehavioral Reviews.2016; 68: 741. CrossRef
Objective Neuropsychiatric symptoms are common in Parkinson’s disease dementia (PDD). Frequent and severe neuropsychiatric symptoms create high levels of distress for patients and caregivers, decreasing their quality of life. The aim of this study was to investigate neuropsychiatric symptoms that may contribute to increased caregiver burden in PDD patients. Methods Forty-eight PDD patients were assessed using the 12-item Neuropsychiatric Inventory (NPI) to determine the frequency and severity of mental and behavioral problems. The Burden Interview and Caregiver Burden Inventory were used to evaluate caregiver burden. Results All but one patient showed one or more neuropsychiatric symptoms. The three most frequent neuropsychiatric symptoms were apathy (70.8%) and anxiety (70.8%), followed by depression (68.7%). More severe neuropsychiatric symptoms were significantly correlated with increased caregiver burden. The domains of delusion, hallucination, agitation and aggression, anxiety, irritability and lability, and aberrant motor behavior were associated with caregiver stress. After controlling for age and other potential confounding variables, total NPI score was significantly associated with caregiver burden. Conclusions The results of this study confirm that neuropsychiatric symptoms are frequent and severe in patients with PDD and are associated with increased caregiver distress. A detailed evaluation and management of neuropsychiatric symptoms in PDD patients appears necessary to improve patient quality of life and reduce caregiver burden.
Citations
Citations to this article as recorded by
Caregiver Burden of Patients With Huntington’s Disease in South Korea Chan Young Lee, Chaewon Shin, Yun Su Hwang, Eungseok Oh, Manho Kim, Hyun Sook Kim, Sun Ju Chung, Young Hee Sung, Won Tae Yoon, Jin Whan Cho, Jae-Hyeok Lee, Han-Joon Kim, Hee Jin Chang, Beomseok Jeon, Kyung Ah Woo, Seong-Beom Koh, Kyum-Yil Kwon, Jangsup Mo Journal of Movement Disorders.2024; 17(1): 30. CrossRef
Risk factors and intervention of caregiver burden in Parkinson’s disease: a systematic review and meta-analysis Yan Zhao, Wenxiang Wu, Jianjun Wu, Bin Shen, Yanpei Cao, Yafang Xu Quality of Life Research.2024; 33(7): 1753. CrossRef
Impact of advanced Parkinson’s disease on caregivers: an international real-world study Pablo Martinez-Martin, Matej Skorvanek, Tove Henriksen, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Prasanna L. Kandukuri, Vivek S. Chaudhari, Apeksha B. Patel, Juan Carlos Parra, James Pike, Angelo Antonini Journal of Neurology.2023; 270(4): 2162. CrossRef
Motor Complications and Treatment in Advanced Parkinson's Disease #456 Caroline E. Olvera, Jori E. Fleisher, Neha M. Kramer Journal of Palliative Medicine.2023; 26(5): 730. CrossRef
A single centre prospective study of three device-assisted therapies for Parkinson’s disease Hugo Morales-Briceño, Ainhi D. Ha, Han-Lin Chiang, Yicheng Tai, Florence C. F. Chang, David S. Tsui, Jane Griffith, Donna Galea, Samuel D. Kim, Belinda Cruse, Neil Mahant, Victor S. C. Fung npj Parkinson's Disease.2023;[Epub] CrossRef
Unawareness of Apathy in Parkinson’s Disease: The Role of Executive Dysfunction on Symptom Recognition Gianpaolo Maggi, Carmine Vitale, Alessia Delle Curti, Marianna Amboni, Gabriella Santangelo Brain Sciences.2023; 13(6): 964. CrossRef
Caregiver Burden in Late-Stage Parkinsonism and Its Associations Stefania Kalampokini, Adrianus L. A. J. Hommel, Stefan Lorenzl, Joaquim J. Ferreira, Wassilios G. Meissner, Per Odin, Bastiaan R. Bloem, Richard Dodel, Anette-Eleonore Schrag Journal of Geriatric Psychiatry and Neurology.2022; 35(1): 110. CrossRef
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries Angelo Antonini, Rajesh Pahwa, Per Odin, Tove Henriksen, Michael J. Soileau, Ramon Rodriguez-Cruz, Stuart H. Isaacson, Aristide Merola, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Yash J. Jalundhwala, Prasanna L. Kandukuri, Juan Carlos Parra, Pavnit Neurology and Therapy.2022; 11(1): 303. CrossRef
Impact of Isolation During the COVID-19 Pandemic on the Patient Burden of Parkinson’s Disease: A PMD Alliance Survey Neal Hermanowicz, Maria Cristina Ospina, Yasar Torres-Yaghi, Sherrie Gould, Kelly Papesh, Jason A Rivera, Susan Miller, Sarah Jones, Kelli Musick, Damian May Neuropsychiatric Disease and Treatment.2022; Volume 18: 633. CrossRef
Exploring the experiences of living with Lewy body dementia: An integrative review Allison Bentley, Tessa Morgan, Yakubu Salifu, Catherine Walshe Journal of Advanced Nursing.2021; 77(12): 4632. CrossRef
Neuropsychiatric symptoms in Parkinson’s disease: association with caregiver distress and disease severity Wan-Chen Tsai, Hui-Chen Lin, Chiung-Chih Chang, Wen-Neng Chang, Chih-Cheng Huang, Kuei-Yueh Cheng, Hung-Chen Wang, Wei-Che Lin, Sheng-Yuan Hsiao, Yun-Ru Lai, Cheng-Hsien Lu, Nai-Wen Tsai International Psychogeriatrics.2020; 32(6): 733. CrossRef
Caregiver Burden, Quality of Life and Related Factors in Family Caregivers of Dementia Patients in Turkey Zeliha Tulek, Dilek Baykal, Sumeyye Erturk, Basar Bilgic, Hasmet Hanagasi, I. Hakan Gurvit Issues in Mental Health Nursing.2020; 41(8): 741. CrossRef
Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice Claudia Lazcano-Ocampo, Yi Min Wan, Daniel J van Wamelen, Lucia Batzu, Iro Boura, Nataliya Titova, Valentina Leta, Mubasher Qamar, Pablo Martinez-Martin, K Ray Chaudhuri Expert Review of Neurotherapeutics.2020; 20(5): 477. CrossRef
A systematic review of the association between individual behavioural and psychological symptoms in dementia and carer burden Catriona George, Nuno Ferreira, Rosalind Evans, Victoria Honeyman Working with Older People.2020; 24(3): 181. CrossRef
Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden
Nicola Modugno, Angelo Antonini, Alessandro Tessitore, Pietro Marano, Francesco Ernesto Pontieri, Nicola Tambasco, Margherita Canesi, Giovanni Fabbrini, Mariachiara Sensi, Rocco Quatrale, Paolo Solla, Giovanni Defazio, Gabriella Melzi, Giuliana Gualberti, Neuropsychiatric Disease and Treatment.2020; Volume 16: 2899. CrossRef
A Comparative Study of the Behavioral Profile of the Behavioral Variant of Frontotemporal Dementia and Parkinson’s Disease Dementia Dinesh Saini, Adreesh Mukherjee, Arijit Roy, Atanu Biswas Dementia and Geriatric Cognitive Disorders Extra.2020; 10(3): 182. CrossRef
The long‐term direct and indirect economic burden among Parkinson's disease caregivers in the United States Pablo Martinez‐Martin, Dendy Macaulay, Yash J. Jalundhwala, Fan Mu, Erika Ohashi, Thomas Marshall, Kavita Sail Movement Disorders.2019; 34(2): 236. CrossRef
The association between specific neuropsychiatric disturbances in people with Alzheimer's disease and dementia with Lewy bodies and carer distress Toril Marie Terum, Ingelin Testad, Arvid Rongve, Dag Aarsland, Ellen Svendsboe, John Roger Andersen International Journal of Geriatric Psychiatry.2019; 34(10): 1421. CrossRef
Trait Impulsivity Is Independent of Mild Cognitive Impairment in a Parkinson’s Disease Cohort Ashani Jeyadevan, Megan C. Bakeberg, Michelle Byrnes, Jade Kenna, Soumya Ghosh, Rick Stell, Sue Walters, Tess Evans, Sarah McGregor, Malcolm Horne, Frank L. Mastaglia, Ryan S. Anderton Parkinson's Disease.2019; 2019: 1. CrossRef
Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study Alessandro Tessitore, Pietro Marano, Nicola Modugno, Francesco E. Pontieri, Nicola Tambasco, Margherita Canesi, Anna Latorre, Leonardo Lopiano, Mariachiara Sensi, Rocco Quatrale, Paolo Solla, Giovanni Defazio, Gabriella Melzi, Anna Maria Costanzo, Giulian Journal of Neurology.2018; 265(5): 1124. CrossRef
Estudio observacional transversal de la sobrecarga en cuidadoras informales y los determinantes relacionados con la atención a las personas dependientes Ana María Rodríguez-González, Eva Rodríguez-Míguez, Ana Duarte-Pérez, Eduardo Díaz-Sanisidro, Ángel Barbosa-Álvarez, Ana Clavería Atención Primaria.2017; 49(3): 156. CrossRef
Cognitive impairment in Parkinson's disease: impact on quality of life of carers RA Lawson, AJ Yarnall, F Johnston, GW Duncan, TK Khoo, D Collerton, JP Taylor, DJ Burn International Journal of Geriatric Psychiatry.2017; 32(12): 1362. CrossRef
Rivastigmine as a Symptomatic Treatment for Apathy in Parkinson’s Dementia Complex: New Aspects for This Riddle Rita Moretti, Paola Caruso, Matteo Dal Ben Parkinson's Disease.2017; 2017: 1. CrossRef
The relationship of specific items on the Neuropsychiatric Inventory to caregiver burden in dementia: a systematic review Toril Marie Terum, John Roger Andersen, Arvid Rongve, Dag Aarsland, Ellen J. Svendsboe, Ingelin Testad International Journal of Geriatric Psychiatry.2017; 32(7): 703. CrossRef
Neuropsychiatric symptoms in Alzheimer’s disease: associations with caregiver burden and treatment outcomes C.T. Chen, C.-C. Chang, W.-N. Chang, N.-W. Tsai, C.-C. Huang, Y.-T. Chang, H.-C. Wang, C.-T. Kung, Y.-J. Su, W.-C. Lin, B.-C. Cheng, C.-M. Su, S.-Y. Hsiao, C.-W. Hsu, C.-H. Lu QJM: An International Journal of Medicine.2017; 110(9): 565. CrossRef
Hallucinations in Healthy Older Adults: An Overview of the Literature and Perspectives for Future Research Johanna C. Badcock, Hedwige Dehon, Frank Larøi Frontiers in Psychology.2017;[Epub] CrossRef
Dementia Caregiver Burden: a Research Update and Critical Analysis Sheung-Tak Cheng Current Psychiatry Reports.2017;[Epub] CrossRef
Patients and Their Caregivers’ Burdens for Parkinson’s Disease in Korea Jong Sam Baik, Joong-Seok Kim, Seong-Beom Koh, Jin Whan Cho, Phil Hyu Lee, Hyeo-Il Ma, Yun Joong Kim, Tae-Beom Ahn, Sang Jin Kim, Yong Duk Kim, Seong-min Choi, Ho-Won Lee, Hee Tae Kim Journal of Movement Disorders.2017; 10(3): 109. CrossRef
Prevalence and treatment pattern ofParkinson's disease dementia inKorea Yoon‐Sang Oh, Joong‐Seok Kim, In‐Seok Park, Yong‐Soo Shim, In‐Uk Song, Jeong‐Wook Park, Phil‐Hyu Lee, Chul‐Hyung Lyoo, Tae‐Beom Ahn, Hyo‐Il Ma, Yong‐Duk Kim, Seong‐Beom Koh, Seung‐Jae Lee, Kwang‐Soo Lee Geriatrics & Gerontology International.2016; 16(2): 230. CrossRef
Genetic architecture for human aggression: A study of gene–phenotype relationship in OMIM Yanli Zhang‐James, Stephen V. Faraone American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.2016; 171(5): 641. CrossRef
The relationship between specific cognitive defects and burden of care in Parkinson's disease Michael Zhong, Richard Peppard, Dennis Velakoulis, Andrew H. Evans International Psychogeriatrics.2016; 28(2): 275. CrossRef
Effect of lumbo-peritoneal shunt surgery on neuropsychiatric symptoms in patients with idiopathic normal pressure hydrocephalus Hideki Kanemoto, Hiroaki Kazui, Yukiko Suzuki, Syunsuke Sato, Haruhiko Kishima, Toshiki Yoshimine, Kenji Yoshiyama Journal of the Neurological Sciences.2016; 361: 206. CrossRef
The safety, tolerability and efficacy of pimavanserin tartrate in the treatment of psychosis in Parkinson’s disease Stefan Hermanowicz, Neal Hermanowicz Expert Review of Neurotherapeutics.2016; 16(6): 625. CrossRef
Neuropsychiatric symptoms in Serbian patients with Parkinson's disease Mirjana Petrovic, Elka Stefanova, Ljubomir Ziropadja, Tanja Stojkovic, Vladimir S. Kostic Journal of the Neurological Sciences.2016; 367: 342. CrossRef
Managing Cognition in Progressive Supranuclear Palsy Timothy Rittman, Ian TS Coyle-Gilchrist, James B Rowe Neurodegenerative Disease Management.2016; 6(6): 499. CrossRef